AU4583397A - Assay for the detection of antibodies against p53 - Google Patents

Assay for the detection of antibodies against p53

Info

Publication number
AU4583397A
AU4583397A AU45833/97A AU4583397A AU4583397A AU 4583397 A AU4583397 A AU 4583397A AU 45833/97 A AU45833/97 A AU 45833/97A AU 4583397 A AU4583397 A AU 4583397A AU 4583397 A AU4583397 A AU 4583397A
Authority
AU
Australia
Prior art keywords
assay
detection
antibodies against
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU45833/97A
Inventor
Daniel T. Mytych
Steven J. Swanson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU4583397A publication Critical patent/AU4583397A/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57496Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54373Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G01N33/5438Electrodes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/82Translation products from oncogenes
AU45833/97A 1996-10-07 1997-10-01 Assay for the detection of antibodies against p53 Abandoned AU4583397A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2853396P 1996-10-07 1996-10-07
US60028533 1996-10-07
PCT/US1997/016132 WO1998015834A1 (en) 1996-10-07 1997-10-01 ASSAY FOR THE DETECTION OF ANTIBODIES AGAINST p53

Publications (1)

Publication Number Publication Date
AU4583397A true AU4583397A (en) 1998-05-05

Family

ID=21843977

Family Applications (1)

Application Number Title Priority Date Filing Date
AU45833/97A Abandoned AU4583397A (en) 1996-10-07 1997-10-01 Assay for the detection of antibodies against p53

Country Status (11)

Country Link
EP (1) EP0929811A1 (en)
JP (1) JP2001502419A (en)
KR (1) KR20000048833A (en)
CN (1) CN1240028A (en)
AU (1) AU4583397A (en)
BR (1) BR9712504A (en)
CA (1) CA2267200A1 (en)
HU (1) HUP9904222A3 (en)
IL (1) IL129323A0 (en)
NZ (1) NZ334809A (en)
WO (1) WO1998015834A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2331786A1 (en) * 1998-06-25 1999-12-29 Institut Pasteur Exhaustive analysis of viral protein interactions by two-hybrid screens and selection of correctly folded viral interacting polypeptides
AUPP932199A0 (en) * 1999-03-19 1999-04-15 St Vincent's Hospital Sydney Limited Anti-p53 antibodies
CN1217194C (en) * 2001-01-04 2005-08-31 上海数康生物科技有限公司 Protein chip and its preparing process and application
EP1403640B1 (en) * 2001-05-07 2007-12-05 HiPep Laboratories Peptide-immobilized baseboard and method of assaying target protein using the same
KR20030092462A (en) * 2002-05-30 2003-12-06 박영미 Method and kit for diagnosis of progress stage of cancer
CA2949753A1 (en) * 2005-12-22 2007-07-05 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
BRPI0907637A8 (en) * 2008-01-25 2018-01-02 P53 Inc p53 biomarkers
JP6119607B2 (en) * 2011-09-20 2017-04-26 コニカミノルタ株式会社 Sample dilution solution, kit using the same, and fluorescence measurement method
US20130196350A1 (en) * 2012-01-31 2013-08-01 Bio-Rad Laboratories, Inc. Sensitivity and specificity for ovarian cancer
PL3201234T3 (en) * 2014-09-30 2019-04-30 Diadem S R L Antibody binding a linear epitope of human p53 and diagnostic applications thereof
CN112964870B (en) * 2021-02-03 2024-01-26 军事科学院军事医学研究院军事兽医研究所 Influenza virus rapid detection method based on SPR biosensor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2698367B1 (en) * 1992-11-02 1995-02-17 Eurobio Lab Fragments of the p53 protein and their uses in the detection and monitoring of disease states.
IL108726A (en) * 1994-02-22 1999-12-31 Yissum Res Dev Co Electrobiochemical method and system for the determination of an analyte which is a member of a recognition pair in a liquid medium and electrodes therefor

Also Published As

Publication number Publication date
EP0929811A1 (en) 1999-07-21
CA2267200A1 (en) 1998-04-16
BR9712504A (en) 1999-10-19
HUP9904222A2 (en) 2000-04-28
WO1998015834A1 (en) 1998-04-16
NZ334809A (en) 2000-12-22
HUP9904222A3 (en) 2000-08-28
KR20000048833A (en) 2000-07-25
CN1240028A (en) 1999-12-29
JP2001502419A (en) 2001-02-20
IL129323A0 (en) 2000-02-17

Similar Documents

Publication Publication Date Title
AU4992997A (en) Humanized anti-cd11a antibodies
AU3811495A (en) Antibodies
AU2635995A (en) Photocleavable agents and conjugates for the detection and isolation of biomolecules
AU8908998A (en) Analyte detection systems
AU6243596A (en) Anti-Fas ligand antibody and assay method using the anti-Fas ligand antibody
AU1141597A (en) Electronically-solid-phase assay biomolecules
AU6364699A (en) Detection of analytes
AU2299497A (en) An assay system and novel labelled compounds for use therewith
AUPP103497A0 (en) Assay apparatus
AU8354098A (en) Fluorescent polymeric sensor for the detection of creatinine
AU1875195A (en) Solid phase assay for detection of ligands
AU2496197A (en) Method for the detection of creatinine
AU3080497A (en) Homogeneous sol-sol assay
AUPM769394A0 (en) Assay for the detection of proteases
AU7294396A (en) Protein detection
AU2980397A (en) Highly sensitive fluorescent immunoassay
AU4583397A (en) Assay for the detection of antibodies against p53
AU5110296A (en) Arrangement for the detection of targets
AU1501697A (en) Improved method for the detection of protein
AU5811498A (en) Microsphere-enhanced immunoassay for the detection of veterinary diseases
AU7713498A (en) Immunoassay for the detection of cancer
AU5970198A (en) Anti-fas antibodies
AUPN366895A0 (en) Detection of small analytes
AU2752897A (en) Formazan-based immunoassay
AU2643495A (en) Assay for pathogenicity of anti-dna antibodies

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted